Copyright Reports & Markets. All rights reserved.

Global MRI Contrast Agent Injector Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global MRI Contrast Agent Injector Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Single-head Injector
    • 1.3.3 Dual-head Injector
  • 1.4 Market Analysis by Injection Dosage
    • 1.4.1 Overview: Global MRI Contrast Agent Injector Consumption Value by Injection Dosage: 2021 Versus 2025 Versus 2032
    • 1.4.2 Injection Dosage: 50-200 mL
    • 1.4.3 Injection Dosage: 20-50 mL
    • 1.4.4 Injection Dosage: 1-20 mL
  • 1.5 Market Analysis by Usage Type
    • 1.5.1 Overview: Global MRI Contrast Agent Injector Consumption Value by Usage Type: 2021 Versus 2025 Versus 2032
    • 1.5.2 Disposable Piping Type
    • 1.5.3 Reusable Type
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global MRI Contrast Agent Injector Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Adults
    • 1.6.3 Children
  • 1.7 Global MRI Contrast Agent Injector Market Size & Forecast
    • 1.7.1 Global MRI Contrast Agent Injector Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global MRI Contrast Agent Injector Sales Quantity (2021-2032)
    • 1.7.3 Global MRI Contrast Agent Injector Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GE Healthcare
    • 2.1.1 GE Healthcare Details
    • 2.1.2 GE Healthcare Major Business
    • 2.1.3 GE Healthcare MRI Contrast Agent Injector Product and Services
    • 2.1.4 GE Healthcare MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GE Healthcare Recent Developments/Updates
  • 2.2 Vygon
    • 2.2.1 Vygon Details
    • 2.2.2 Vygon Major Business
    • 2.2.3 Vygon MRI Contrast Agent Injector Product and Services
    • 2.2.4 Vygon MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Vygon Recent Developments/Updates
  • 2.3 LnkMed
    • 2.3.1 LnkMed Details
    • 2.3.2 LnkMed Major Business
    • 2.3.3 LnkMed MRI Contrast Agent Injector Product and Services
    • 2.3.4 LnkMed MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 LnkMed Recent Developments/Updates
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer MRI Contrast Agent Injector Product and Services
    • 2.4.4 Bayer MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Recent Developments/Updates
  • 2.5 Medtron
    • 2.5.1 Medtron Details
    • 2.5.2 Medtron Major Business
    • 2.5.3 Medtron MRI Contrast Agent Injector Product and Services
    • 2.5.4 Medtron MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Medtron Recent Developments/Updates
  • 2.6 Antmed
    • 2.6.1 Antmed Details
    • 2.6.2 Antmed Major Business
    • 2.6.3 Antmed MRI Contrast Agent Injector Product and Services
    • 2.6.4 Antmed MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Antmed Recent Developments/Updates
  • 2.7 Ulrichmedical
    • 2.7.1 Ulrichmedical Details
    • 2.7.2 Ulrichmedical Major Business
    • 2.7.3 Ulrichmedical MRI Contrast Agent Injector Product and Services
    • 2.7.4 Ulrichmedical MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ulrichmedical Recent Developments/Updates
  • 2.8 SINO MDT
    • 2.8.1 SINO MDT Details
    • 2.8.2 SINO MDT Major Business
    • 2.8.3 SINO MDT MRI Contrast Agent Injector Product and Services
    • 2.8.4 SINO MDT MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 SINO MDT Recent Developments/Updates
  • 2.9 Leriva
    • 2.9.1 Leriva Details
    • 2.9.2 Leriva Major Business
    • 2.9.3 Leriva MRI Contrast Agent Injector Product and Services
    • 2.9.4 Leriva MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Leriva Recent Developments/Updates
  • 2.10 Bracco
    • 2.10.1 Bracco Details
    • 2.10.2 Bracco Major Business
    • 2.10.3 Bracco MRI Contrast Agent Injector Product and Services
    • 2.10.4 Bracco MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bracco Recent Developments/Updates
  • 2.11 APOLLO RT
    • 2.11.1 APOLLO RT Details
    • 2.11.2 APOLLO RT Major Business
    • 2.11.3 APOLLO RT MRI Contrast Agent Injector Product and Services
    • 2.11.4 APOLLO RT MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 APOLLO RT Recent Developments/Updates
  • 2.12 Guerbet
    • 2.12.1 Guerbet Details
    • 2.12.2 Guerbet Major Business
    • 2.12.3 Guerbet MRI Contrast Agent Injector Product and Services
    • 2.12.4 Guerbet MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Guerbet Recent Developments/Updates
  • 2.13 Nemoto Kyorindo
    • 2.13.1 Nemoto Kyorindo Details
    • 2.13.2 Nemoto Kyorindo Major Business
    • 2.13.3 Nemoto Kyorindo MRI Contrast Agent Injector Product and Services
    • 2.13.4 Nemoto Kyorindo MRI Contrast Agent Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Nemoto Kyorindo Recent Developments/Updates

3 Competitive Environment: MRI Contrast Agent Injector by Manufacturer

  • 3.1 Global MRI Contrast Agent Injector Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global MRI Contrast Agent Injector Revenue by Manufacturer (2021-2026)
  • 3.3 Global MRI Contrast Agent Injector Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of MRI Contrast Agent Injector by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 MRI Contrast Agent Injector Manufacturer Market Share in 2025
    • 3.4.3 Top 6 MRI Contrast Agent Injector Manufacturer Market Share in 2025
  • 3.5 MRI Contrast Agent Injector Market: Overall Company Footprint Analysis
    • 3.5.1 MRI Contrast Agent Injector Market: Region Footprint
    • 3.5.2 MRI Contrast Agent Injector Market: Company Product Type Footprint
    • 3.5.3 MRI Contrast Agent Injector Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global MRI Contrast Agent Injector Market Size by Region
    • 4.1.1 Global MRI Contrast Agent Injector Sales Quantity by Region (2021-2032)
    • 4.1.2 Global MRI Contrast Agent Injector Consumption Value by Region (2021-2032)
    • 4.1.3 Global MRI Contrast Agent Injector Average Price by Region (2021-2032)
  • 4.2 North America MRI Contrast Agent Injector Consumption Value (2021-2032)
  • 4.3 Europe MRI Contrast Agent Injector Consumption Value (2021-2032)
  • 4.4 Asia-Pacific MRI Contrast Agent Injector Consumption Value (2021-2032)
  • 4.5 South America MRI Contrast Agent Injector Consumption Value (2021-2032)
  • 4.6 Middle East & Africa MRI Contrast Agent Injector Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global MRI Contrast Agent Injector Sales Quantity by Type (2021-2032)
  • 5.2 Global MRI Contrast Agent Injector Consumption Value by Type (2021-2032)
  • 5.3 Global MRI Contrast Agent Injector Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global MRI Contrast Agent Injector Sales Quantity by Application (2021-2032)
  • 6.2 Global MRI Contrast Agent Injector Consumption Value by Application (2021-2032)
  • 6.3 Global MRI Contrast Agent Injector Average Price by Application (2021-2032)

7 North America

  • 7.1 North America MRI Contrast Agent Injector Sales Quantity by Type (2021-2032)
  • 7.2 North America MRI Contrast Agent Injector Sales Quantity by Application (2021-2032)
  • 7.3 North America MRI Contrast Agent Injector Market Size by Country
    • 7.3.1 North America MRI Contrast Agent Injector Sales Quantity by Country (2021-2032)
    • 7.3.2 North America MRI Contrast Agent Injector Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe MRI Contrast Agent Injector Sales Quantity by Type (2021-2032)
  • 8.2 Europe MRI Contrast Agent Injector Sales Quantity by Application (2021-2032)
  • 8.3 Europe MRI Contrast Agent Injector Market Size by Country
    • 8.3.1 Europe MRI Contrast Agent Injector Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe MRI Contrast Agent Injector Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific MRI Contrast Agent Injector Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific MRI Contrast Agent Injector Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific MRI Contrast Agent Injector Market Size by Region
    • 9.3.1 Asia-Pacific MRI Contrast Agent Injector Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific MRI Contrast Agent Injector Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America MRI Contrast Agent Injector Sales Quantity by Type (2021-2032)
  • 10.2 South America MRI Contrast Agent Injector Sales Quantity by Application (2021-2032)
  • 10.3 South America MRI Contrast Agent Injector Market Size by Country
    • 10.3.1 South America MRI Contrast Agent Injector Sales Quantity by Country (2021-2032)
    • 10.3.2 South America MRI Contrast Agent Injector Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa MRI Contrast Agent Injector Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa MRI Contrast Agent Injector Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa MRI Contrast Agent Injector Market Size by Country
    • 11.3.1 Middle East & Africa MRI Contrast Agent Injector Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa MRI Contrast Agent Injector Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 MRI Contrast Agent Injector Market Drivers
  • 12.2 MRI Contrast Agent Injector Market Restraints
  • 12.3 MRI Contrast Agent Injector Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of MRI Contrast Agent Injector and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of MRI Contrast Agent Injector
  • 13.3 MRI Contrast Agent Injector Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 MRI Contrast Agent Injector Typical Distributors
  • 14.3 MRI Contrast Agent Injector Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global MRI Contrast Agent Injector market size was valued at US$ 368 million in 2025 and is forecast to a readjusted size of US$ 608 million by 2032 with a CAGR of 7.4% during review period.
    In 2025, global sales of MRI contrast agent injectors reached 4.2 million units, with an average selling price of $85, total production capacity of approximately 5 million units, and a gross profit margin of approximately 38%. This product is a medical device used for the precise and controllable injection of contrast agents during MRI imaging examinations. It mainly includes a programmable infusion pump, a pressure sensing system, and disposable injection tubing components, ensuring the safe delivery of contrast agents within the body and maintaining imaging quality. Upstream raw materials include polymer plastics, medical-grade silicone, precision metal valves, and electronic sensors; downstream supply mainly consists of large hospitals, imaging centers, and health checkup institutions.
    In the future, with the increase in global MRI examinations, the development of precision medicine and personalized diagnosis and treatment, and the trend of high-end medical devices replacing traditional injectors, the demand for MRI contrast agent injectors will continue to rise. Business opportunities are mainly concentrated in high-precision programmable injection systems, low-residue contrast agent technology, and automated imaging solutions.
    The MRI contrast agent injector market is experiencing steady growth, driven by rising global demand for medical imaging and the trend towards precision medicine. As hospitals and imaging centers increasingly rely on high-precision, controllable injection systems, traditional manual injection methods are gradually being replaced by programmable, high-safety injectors, particularly in large hospitals and high-end imaging centers, where growth has been significant.
    Furthermore, the aging population and increased MRI prevalence are driving overall market demand to expand, simultaneously propelling manufacturers towards high-precision, low-residue, automated, and intelligent product development. While upstream raw material supply remains stable, high-precision electronic sensors and disposable injection tubing remain key cost and technological factors. Downstream consumption is consolidating, with large hospitals and imaging centers accounting for a large share, primarily in North America, Europe, and the Asia-Pacific region.
    In the future, with the development of telemedicine, mobile imaging services, and personalized medicine, MRI contrast agent injectors will not only exist as basic medical consumables but will also be deeply integrated with intelligent imaging equipment and software management systems, forming new value-added services and business models, providing companies with continuous market expansion opportunities and technological innovation opportunities.
    This report is a detailed and comprehensive analysis for global MRI Contrast Agent Injector market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global MRI Contrast Agent Injector market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global MRI Contrast Agent Injector market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global MRI Contrast Agent Injector market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global MRI Contrast Agent Injector market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for MRI Contrast Agent Injector
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global MRI Contrast Agent Injector market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Vygon, LnkMed, Bayer, Medtron, Antmed, Ulrichmedical, SINO MDT, Leriva, Bracco, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    MRI Contrast Agent Injector market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Single-head Injector
    Dual-head Injector
    Market segment by Injection Dosage
    Injection Dosage: 50-200 mL
    Injection Dosage: 20-50 mL
    Injection Dosage: 1-20 mL
    Market segment by Usage Type
    Disposable Piping Type
    Reusable Type
    Market segment by Application
    Adults
    Children
    Major players covered
    GE Healthcare
    Vygon
    LnkMed
    Bayer
    Medtron
    Antmed
    Ulrichmedical
    SINO MDT
    Leriva
    Bracco
    APOLLO RT
    Guerbet
    Nemoto Kyorindo
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe MRI Contrast Agent Injector product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of MRI Contrast Agent Injector, with price, sales quantity, revenue, and global market share of MRI Contrast Agent Injector from 2021 to 2026.
    Chapter 3, the MRI Contrast Agent Injector competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the MRI Contrast Agent Injector breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and MRI Contrast Agent Injector market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of MRI Contrast Agent Injector.
    Chapter 14 and 15, to describe MRI Contrast Agent Injector sales channel, distributors, customers, research findings and conclusion.

    Buy now